Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160,377,960
-
Total 13F shares
-
33,506,756
-
Share change
-
+28,339,341
-
Total reported value
-
$376,279,000
-
Price per share
-
$11.23
-
Number of holders
-
66
-
Value change
-
+$318,247,827
-
Number of buys
-
59
Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q4 2020
As of 31 Dec 2020,
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,506,756 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Ally Bridge Group (NY) LLC, Fairmount Funds Management LLC, BVF INC/IL, Polar Capital Holdings Plc, Ghost Tree Capital, LLC, VR Adviser, LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.